Cutispharma Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Cutispharma Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10806
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
CutisPharma Inc (CutisPharma) is a pharmaceutical company that develops and distributes kits. The company offers products such as oral suspensions, suppositories, oral solutions, and topical, among others. Its oral solutions and oral suspensions include mouthwashes, anti-microbial, and PPIs; and topicals comprise hydrocortisone and testosterone; and suppositories include progesterone VGS, among others. CutisPharma also provides facilities for distribution, warehousing, and manufacturing operations and management. The company serves hospital and long term care pharmacies, pharmacy chains, and independent pharmacies. It provides prescription compounding kits for physicians, patients, pharmacists, and managed care providers. CutisPharma is headquartered in Wilmington, Massachusetts, the US.

Cutispharma Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Cutispharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Cutispharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Cutispharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Cutispharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8
Cutispharma Inc, Pharmaceuticals & Healthcare, Deal Details 9
Venture Financing 9
CutisPharma Secures Funds from Silicon Valley Bank 9
CutisPharma Raises USD20 Million in Venture Financing 10
Private Equity 11
NovaQuest Capital Acquires Cutispharma 11
Ampersand Capital Invests in CutisPharma 12
Partnerships 13
CutisPharma Partners with Dr. Reddy’s Labs 13
Cutispharma Inc – Key Competitors 14
Cutispharma Inc – Key Employees 15
Cutispharma Inc – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Corporate Communications 17
Aug 01, 2017: CutisPharma Announces Executive Team And Board Appointments 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Cutispharma Inc, Pharmaceuticals & Healthcare, Key Facts 2
Cutispharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
Cutispharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Cutispharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Cutispharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Cutispharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8
CutisPharma Secures Funds from Silicon Valley Bank 9
CutisPharma Raises USD20 Million in Venture Financing 10
NovaQuest Capital Acquires Cutispharma 11
Ampersand Capital Invests in CutisPharma 12
CutisPharma Partners with Dr. Reddy's Labs 13
Cutispharma Inc, Key Competitors 14
Cutispharma Inc, Key Employees 15
Cutispharma Inc, Other Locations 16

List of Figures
Cutispharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Cutispharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Cutispharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Cutispharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Cutispharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Cutispharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

★海外企業調査レポート[Cutispharma Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Visteon Corporation:企業のM&A・事業提携・投資動向
    Visteon Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Visteon Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Urenco Ltd:企業の戦略・SWOT・財務分析
    Urenco Ltd - Strategy, SWOT and Corporate Finance Report Summary Urenco Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Treatt Plc:企業の戦略・SWOT・財務情報
    Treatt Plc - Strategy, SWOT and Corporate Finance Report Summary Treatt Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • SS&C Advent:企業の戦略的SWOT分析
    SS&C Advent - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Cognition Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Cognition Therapeutics Inc (CogRx) is a drug discovery and development company that discovers and develops small molecule therapeutics. The company uses its proprietary biology and chemistry platforms for the development of novel drug targets and disease modifying therapies for the treatment …
  • Questerre Energy Corp (QEC):企業の財務・戦略的SWOT分析
    Summary Questerre Energy Corp (Questerre) is an independent oil and gas exploration and development company that acquires, explores, develops and produces unconventional oil and gas properties. The company’s unconventional properties include tight oil, shale oil and shale gas. It has base production …
  • Autotelic Inc-製薬・医療分野:企業M&A・提携分析
    Summary Autotelic Inc (Autotelic) is a therapeutic drug monitoring company that develops novel treatments using its therapeutic drug monitoring (TDM) services. The company's pipeline products includes devices to improve safety and efficacy of COX-2 inhibitors, paclitaxel nanomedicine and TGF-beta in …
  • S2Medical AB:製品パイプライン分析
    Summary S2Medical AB (S2Medical) is a medical technology company that designs, develops and markets wound dressings and products to treat burns and chronic ulcers. The company’s product portfolio consists of wound dressing patches; blood stilling synthetic epithelium dressing to control capillary bl …
  • CDW Corporation:企業の戦略・SWOT・財務情報
    CDW Corporation - Strategy, SWOT and Corporate Finance Report Summary CDW Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Tyler Technologies Inc (TYL):企業の財務・戦略的SWOT分析
    Tyler Technologies Inc (TYL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Caterpillar Inc (CAT)-エネルギー分野:企業M&A・提携分析
    Summary Caterpillar Inc. (Caterpillar) is a manufacturer of construction, transportation and energy equipment. It designs, manufactures, markets and sells construction and mining equipment, industrial gas turbines, forestry machinery, diesel and natural gas engines, and diesel-electric locomotives. …
  • Saudi Chemical Company (2230):企業の財務・戦略的SWOT分析
    Saudi Chemical Company (2230) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Blue Sky Uranium Corp. (BSK):企業の財務・戦略的SWOT分析
    Blue Sky Uranium Corp. (BSK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Unipol Gruppo Finanziario S.p.A.:戦略・SWOT・企業財務分析
    Unipol Gruppo Finanziario S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Unipol Gruppo Finanziario S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Nishio Rent All Co Ltd (9699):企業の財務・戦略的SWOT分析
    Nishio Rent All Co Ltd (9699) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Somnomed Ltd (SOM):企業の財務・戦略的SWOT分析
    Summary Somnomed Ltd (SomnoMed) is a medical device company that develops, produces, commercializes and markets devices for the oral treatment of sleep-related disorders. The company’s products include Somnodent, an oral appliance for obstructive sleep apnea; and Somnobrux, a mouthguard that protect …
  • PQ Group Holdings Inc (PQG):企業の財務・戦略的SWOT分析
    PQ Group Holdings Inc (PQG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Center For Diagnostic Imaging Inc-医療機器分野:企業M&A・提携分析
    Summary Center For Diagnostic Imaging Inc (CDI), a subsidiary of InSight Health Services Holdings Corp is a healthcare center that patient care services. The center offers upright MRI, diagnostic breast imaging exams, breast biopsies, open CDI vascular care, open upright MRI, nuclear medicine, ultra …
  • GeNeuro SA (GNRO):企業の財務・戦略的SWOT分析
    Summary GeNeuro SA (GeNeuro) operates as a clinical stage pharmaceutical company that manufactures therapeutic product pipeline for disorders of the nervous system. The company provides treatments against inflammatory and degenerative disorders associated with endogenous retroviruses. GeNeuro develo …
  • Advanced Proteome Therapeutics Corp (APC):企業の財務・戦略的SWOT分析
    Advanced Proteome Therapeutics Corp (APC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆